These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
577 related articles for article (PubMed ID: 32969465)
1. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer. Chen J; Wu R; Xuan Y; Jiang M; Zeng Y Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis. Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076 [TBL] [Abstract][Full Text] [Related]
3. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis. Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846 [No Abstract] [Full Text] [Related]
4. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1. Khedkar HN; Wang YC; Yadav VK; Srivastava P; Lawal B; Mokgautsi N; Sumitra MR; Wu ATH; Huang HS Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072728 [TBL] [Abstract][Full Text] [Related]
5. Identification and validation of key genes associated with non-small-cell lung cancer. Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of the circRNA-miRNA-mRNA network for non-small cell lung cancer. Cai X; Lin L; Zhang Q; Wu W; Su A J Int Med Res; 2020 Jun; 48(6):300060520929167. PubMed ID: 32527185 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related]
8. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis. Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of non-small-cell lung cancer microarray datasets identifies several prognostic biomarkers. Qin X; Chen R; Xiong R; Tan Z; Gao S; Lin C; Huo T Future Oncol; 2019 Sep; 15(27):3135-3148. PubMed ID: 31426680 [No Abstract] [Full Text] [Related]
10. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer. Liu X; Liu X; Li J; Ren F Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030 [TBL] [Abstract][Full Text] [Related]
11. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer. Yang Q; Yu B; Sun J Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948 [TBL] [Abstract][Full Text] [Related]
12. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis. Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979 [TBL] [Abstract][Full Text] [Related]
13. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay. Zhang L; Sun L; Zhang B; Chen L Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312 [TBL] [Abstract][Full Text] [Related]
14. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses. Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis. Chen X; Wang J; Peng X; Liu K; Zhang C; Zeng X; Lai Y Medicine (Baltimore); 2020 Apr; 99(14):e19628. PubMed ID: 32243390 [TBL] [Abstract][Full Text] [Related]
16. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related]
17. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms. Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659 [TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis reveals 6 key biomarkers associated with non-small-cell lung cancer. Dai B; Ren LQ; Han XY; Liu DJ J Int Med Res; 2020 Mar; 48(3):300060519887637. PubMed ID: 31775549 [TBL] [Abstract][Full Text] [Related]
19. RBBP4: A novel diagnostic and prognostic biomarker for non-small-cell lung cancer correlated with autophagic cell death. Zhan Y; Zhang Z; Yin A; Su X; Tang N; Chen Y; Zhang Z; Chen W; Wang J; Wang W Cancer Med; 2024 Aug; 13(15):e70090. PubMed ID: 39109577 [TBL] [Abstract][Full Text] [Related]
20. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer. Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]